
Julien Van Damme
@vandamme_jvd
ID: 857119723783426048
26-04-2017 06:30:41
33 Tweet
66 Takipçi
128 Takip Edilen



🚨 External validation of the Briganti 2019 nomogram predicting LNI Urologic Oncology sciencedirect.com/science/articl… Thierry Roumeguere Simone Albisinni Marco Oderda Georges Fournier @GaelleFiard Jean Luc Descotes Grégoire Assenmacher Peltier Alexandre Jean-Baptiste Roche Julien Van Damme Paolo Gontero #prostatecancer



Manon Dewandre présente son évaluation urodynamique des bandelettes sous-urethrales trans-obturatrices dans l'incontinence d'effort après prostactectomie. Société Belge d'Urologie Thierry Roumeguere corona.walrus Julien Van Damme AFrançoise Spinoit Cliniques universitaires Saint-Luc Université de Liège Université libre de Bruxelles

Join us this morning for the graduation of the French speaking urologists in Société Belge d'Urologie #Belgium Maggie De Block Thierry Roumeguere Université libre de Bruxelles corona.walrus Julien Van Damme Cliniques universitaires Saint-Luc Assenmacher Université de Liège AFrançoise Spinoit online graduation!



Fertility preservation in #TesticularCancer patients. Presentation by Julien Van Damme. #ESOU21 written coverage by Zach Klaassen Georgia Cancer Center on UroToday > bit.ly/36ojabX European Association of Urology (EAU) European School of Urology (EAU ESU) EAU Edu Platform UROONCO


There is more than PET-PSMA to monitor tumor response in advance PCa. Julien Van Damme Vassiliki Pasoglou fred lecouvet Anwar Padhani sciencedirect.com/science/articl…


Nice talk by Dr Masson-Lecomte on the importance of defining the response to NAT, as well as the importance of multimodal assessment. Question will be answered by the EORTC2418 - ‘STARBURST’ study !#EORTC #EMUC24 Yohann Loriot Vérane Achard Julien Van Damme Guillaume Grs tombal


Check out our free 20-minute webinar with a multidisciplinary panel of experts discussing the most recent data from clinical trials, treatment (de)escalation, and the role of ultra-low PSA in #mHSPC Register for free at library.mirrorsmed.org/?utm_code=SoMe… Julien Van Damme OncoAlert #GU


Shilpa Gupta Andrea Necchi Dr. Jason Efstathiou Toni Choueiri, MD Rana McKay, MD, FASCO Sumanta K. Pal, MD, FASCO Jonathan Rosenberg MD IBCG We have performed a review dedicated to this topic... Just submitted. 🙏 With Huck constance Vérane Achard Evanguelos Xylinas Morgan Roupret tombal Dr. Jason Efstathiou Julien Van Damme Prof Ananya💙 @achoud72.bsky.social ✨Trial to come... 🤞 Vérane Achard


🚀Congratulations to Dr Guillaume Grs & Dr Julien Van Damme for presenting the groundbreaking EORTC-2418-GUCG STARBURST-1 study last week at #ASCOGU in San Francisco! This study aims to redefine treatment for muscle-invasive #BladderCancer. 👉urotoday.com/conference-hig… ASCO

Merci aux intervenants Morgan Roupret Pignot Géraldine Evanguelos Xylinas Roubaud Guilhem Wes Kassouf Alejandro (Ale) Berlin Genevieve LOOS Paul Sargos ➡️ Vidéo dédiée aux patients Cancer Vessie France Bladder Cancer Advocacy Network BladderCancerCanada Bladder Cancer Canada | Montreal Walk World Bladder Cancer Patient Coalition Fight Bladder Cancer



🚨 Defining clinical response to neoadjuvant CT in bladder is crucial to offer bladder-sparing strategies in complete or near cplt responders ! EORTC Starbust-1 will launch soon Alex Masson-Lecomte EORTC Yohann Loriot tombal Vérane Achard Julien Van Damme sciencedirect.com/science/articl…

